Netherton's syndrome
Not recruitingStudy on the Safety of DS-2325a for Patients with Netherton Syndrome
Study on the Safety of DS-2325a for Patients with Netherton Syndrome
- Disease:Netherton's syndrome
- Substances:–
France- Participants:18–64 years
Rare diseases
Investigational molecules
Locations
Study on the Safety of DS-2325a for Patients with Netherton Syndrome
FranceStudy on Crovalimab for Preventing Painful Episodes in Sickle Cell Disease Patients
FranceStudy on the Tolerability and Effectiveness of Tirbanibulin for Patients with Actinic Cheilitis
GermanyStudy on JNJ-81201887 for Treating Geographic Atrophy in Age-related Macular Degeneration Patients
BelgiumStudy on Volixibat for Treating Itching in Patients with Primary Sclerosing Cholangitis
BelgiumStudy of Magrolimab and Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Stem Cell Transplantation
GermanyStudy of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema
BulgariaStudy on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients
GermanyStudy of BMS-986442 and Nivolumab, Alone or with Chemotherapy, for Patients with Advanced Solid Tumors and Non-Small Cell Lung Cancer
ItalyStudy on the Safety and Effectiveness of ABBV-668 for Adults with Moderate to Severe Ulcerative Colitis
BelgiumStudy of Obexelimab for Patients with Warm Autoimmune Hemolytic Anemia
ItalyStudy on the Effectiveness of Citicoline Eye Drops for Visual Field Preservation in Patients with Open Angle Glaucoma
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.